Gladstone NOW: The Campaign Join Us on the Journey✕
Scientists at Gladstone Institutes figured out why some people naturally control HIV even after stopping therapy—and how we can leverage that to treat others.
People living with HIV need to follow a daily regimen of medications (known as antiretroviral therapy) for the rest of their lives. If they stop, the virus usually rushes back within weeks. But a few rare individuals keep the virus under control for months, or even years, after stopping antiretroviral therapy.
Nadia Roan and her team set out to understand why this happens by examining blood samples from people with HIV who participated in clinical trials, during which they deliberately stopped therapy.
In this video, Nadia Roan and Ashley George explain how they uncovered a new path toward long-term health without the need for daily HIV pills.
Their new study, published in Immunity, shows that metformin, a common diabetes drug, might be able to delay—or even prevent—HIV rebound. The scientists are now working to advance their findings into clinical trials that test whether metformin can help suppress HIV.
Gladstone NOW: The Campaign
Join Us On The Journey
From fundamental insights to translational advances, here’s how Gladstone researchers moved science forward in 2025.
Gladstone Experts Alzheimer’s Disease Autoimmune Diseases COVID-19 Neurological Disease Genomic Immunology Cardiovascular Disease Data Science and Biotechnology Infectious Disease Conklin LabIn this video, Gladstone scientists share how they used stem cells, gene editing, and AI to identify a gene driving heart defects in Down syndrome—and how reducing its levels in mice restored normal heart development, offering hope for future treatments
Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Pollard Lab Srivastava Lab AI Big Data CRISPR/Gene Editing Human Genetics Stem Cells/iPSCsIn this video, Steve Finkbeiner and Jeremy Linsley showcase Gladstone’s groundbreaking “thinking microscope”—an AI-powered system that can design, conduct, and analyze experiments autonomously to uncover new insights into diseases like Alzheimer’s, Parkinson’s, and ALS.
Gladstone Experts ALS Alzheimer’s Disease Parkinson’s Disease Neurological Disease Finkbeiner Lab AI Big Data